UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 28, 2021 4:00 P.M.

Form:	S-1
CIK: 0001650648 Company Name: 4D Molecular Therapeutics Inc. File Number: 333-260508